CP Reports

Welcome to the home of CP Reports, we are the only publisher of life science deal term reports in the industry.

We offer over 200 report titles that focus upon different deal types from co-promotion to distribution, all of which provide you with an insight into the latest life science deal making trends.

Browse our reports by type to find your ideal match.

 

Our reports are updated regularly and include full coverage of all the deals made in the chosen report type.

Unsure which report to select? contact our report analysts who will assist your decision.

Items 1 to 10 of 54 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction
  1. Global Targeted Drug Delivery Partnering 2012-2018

    Global Targeted Drug Delivery Partnering 2012-2018

    $1,995.00

    Publication date: Sep 2018 | Publisher: Current Partnering

    Global Targeted Drug Delivery Partnering 2012-2018 report provides understanding and access to the targeted drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.

    Learn More
  2. Global Oncology Partnering 2012-2018: Deal trends, players and financials

    Global Oncology Partnering 2012-2018: Deal trends, players and financials

    $3,495.00

    Publication date: Sep 2018 | Publisher: Current Partnering

    The Global Oncology Partnering 2012-2018: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the oncology/cancer partnering deals and agreements entered into by the worlds leading healthcare companies

    Learn More
  3. Global Central Nervous System Partnering 2012 to 2018: Deal trends, players and financials

    Global Central Nervous System Partnering 2012 to 2018: Deal trends, players and financials

    $2,995.00

    Publication date: Sep 2018 | Publisher: Current Partnering

    The Global Central Nervous System Partnering 2012 to 2018: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the central nervous system (cns) partnering deals and agreements entered into by the worlds leading healthcare companies. Learn More
  4. Global Dermatology Partnering 2012-2018: Deal trends, players and financials

    Global Dermatology Partnering 2012-2018: Deal trends, players and financials

    $2,995.00

    Publication date: Sep 2018 | Publisher: Current Partnering

    The Global Dermatology Partnering 2012-2018 report provides comprehensive understanding and unprecedented access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies Learn More
  5. Global Autoimmune Partnering 2012-2018: Deal trends, players and financials

    Global Autoimmune Partnering 2012-2018: Deal trends, players and financials

    $2,995.00

    Publication date: Sep 2018 | Publisher: Current Partnering

    The Global Autoimmune Partnering 2012-2018: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the autoimmune disease partnering deals and agreements entered into by the worlds leading healthcare companies

    Learn More
  6. Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2018

    Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2018

    $2,995.00

    Publication date: Oct 2018 | Publisher: Current Partnering

    The Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies.

    Learn More
  7. Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018

    Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018

    $1,995.00

    Publication date: Oct 2018 | Publisher: Current Partnering

    The Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies. Learn More
  8. Global Bioinformatics Partnering Terms and Agreements 2012 to 2018

    Global Bioinformatics Partnering Terms and Agreements 2012 to 2018

    $2,995.00

    Publication date: Oct 2018 | Publisher: Current Partnering

    The Global Bioinformatics Partnering Terms and Agreements 2012 to 2018 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies.

    Learn More
  9. Global Pharmacogenomics Partnering Terms and Agreements 2010 to 2018

    Global Pharmacogenomics Partnering Terms and Agreements 2010 to 2018

    $2,995.00

    Publication date: Oct 2018 | Publisher: Current Partnering

    The Global Pharmacogenomics Partnering Terms & Agreements 2010 to 2018 report provides comprehensive understanding and unprecedented access to the pharmacogenomics partnering deals and agreements entered into by the worlds leading healthcare companies.

    Learn More
  10. Global Monoclonal Antibody Partnering Terms and Agreements 2012 to 2018: Deal trends, players, financials and forecasts

    Global Monoclonal Antibody Partnering Terms and Agreements 2012 to 2018: Deal trends, players, financials and forecasts

    $2,995.00

    Publication date: Oct 2018 | Publisher: Current Partnering

    The Global Monoclonal Antibody Partnering Terms and Agreements 2012 to 2018 report provides comprehensive understanding and unprecedented access to the monoclonal antibodies partnering deals and agreements entered into by the worlds leading healthcare companies.

    Learn More

Items 1 to 10 of 54 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction
© 2019 Wildwood Ventures Ltd.